Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson’s disease. Mov Disord 2016;31:1366-72. | USF Parkinson's Disease and Movement Disorders Center

Hauser, RA, CW Olanow, B Dzyngel, T Bilbault, H Shill, S Isaacson, J Dubow, and A Agro. 2016. “Sublingual Apomorphine (APL-130277) for the Acute Conversion of OFF to ON in Parkinson’s Disease. Mov Disord 2016;31:1366-72.”. Mov Disord.

Last updated on 10/02/2024